D3 Bio

About:

D3 Bio is a biotechnology company focusing on the development and registration of medicines.

Top Investors: Temasek Holdings, Matrix Partners China, HongShan, WuXi AppTec, Medicxi

Description:

D3 Bio is a biotechnology company that focuses on discovering and creating medications in oncology and immunology. The company combines clinical and market data to identify shortcomings in existing conventional medicines, employs unique drug development methodologies aimed at new disease targets and delivery routes, and provides patients with therapy alternatives in immunology and oncology.

Total Funding Amount:

$262M

Headquarters Location:

Shangai, Jiangxi, China

Founded Date:

2020-01-01

Founders:

George Chen, John Jin

Number of Employees:

1-10

Last Funding Date:

2024-04-08

IPO Status:

Private

Industries: